During the past decade, Yoshimura Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yoshimura Clinic" are "Type 2 Diabetes" (2 trials), "Diabetes" (1 trials), "Diabetes Mellitus" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Endocrine System Diseases" (1 trials). Many other conditions were trialed in "Yoshimura Clinic" in a lesser frequency.

Most popular intervention types in "Yoshimura Clinic" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (2 trials), "Alpha-Glucosidase Inhibitors (α-GI)" (1 trials), "Biguanide (BG)" (1 trials), "Glinides (GLN)" (1 trials) and "Insulin Degludec" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yoshimura Clinic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Yoshimura Clinic". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yoshimura Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yoshimura Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".